[go: up one dir, main page]

DK1380591T3 - Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf - Google Patents

Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf

Info

Publication number
DK1380591T3
DK1380591T3 DK03292132T DK03292132T DK1380591T3 DK 1380591 T3 DK1380591 T3 DK 1380591T3 DK 03292132 T DK03292132 T DK 03292132T DK 03292132 T DK03292132 T DK 03292132T DK 1380591 T3 DK1380591 T3 DK 1380591T3
Authority
DK
Denmark
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
DK03292132T
Other languages
Danish (da)
English (en)
Inventor
Thierry Dubuffet
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1380591T3 publication Critical patent/DK1380591T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03292132T 2003-08-29 2003-08-29 Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf DK1380591T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03292132A EP1380591B1 (fr) 2003-08-29 2003-08-29 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
DK1380591T3 true DK1380591T3 (da) 2006-01-23

Family

ID=29724624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03292132T DK1380591T3 (da) 2003-08-29 2003-08-29 Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf

Country Status (18)

Country Link
US (1) US7534896B2 (xx)
EP (1) EP1380591B1 (xx)
JP (1) JP4331206B2 (xx)
CN (1) CN100383160C (xx)
AR (1) AR045516A1 (xx)
AT (1) ATE310012T1 (xx)
AU (1) AU2004270428B2 (xx)
DE (1) DE60302287T2 (xx)
DK (1) DK1380591T3 (xx)
EA (1) EA008668B1 (xx)
ES (1) ES2252633T3 (xx)
HK (1) HK1096408A1 (xx)
MY (1) MY136638A (xx)
NZ (1) NZ545336A (xx)
PL (1) PL211508B1 (xx)
SI (1) SI1380591T1 (xx)
WO (1) WO2005023842A1 (xx)
ZA (1) ZA200601429B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2250853T3 (es) * 2003-08-29 2006-04-16 Les Laboratoires Servier Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables.
DE602005009918D1 (de) 2005-01-06 2008-11-06 Ipca Lab Ltd Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
DK2318365T3 (en) 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
JP6753699B2 (ja) * 2016-05-27 2020-09-09 ミネベアミツミ株式会社 転がり軸受

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1319668T3 (da) * 2003-03-12 2005-02-14 Servier Lab Fremgangsmåde til syntese af (2S, 3aS, 7aS)-1-((S)-alanyl)-octahydro-1H-indol-2-carboxylsyrederivater og anvendelse heraf ved syntese af perindopril
SI1321471T1 (xx) 2003-03-12 2005-08-31 Servier Lab
DK1367061T3 (da) * 2003-06-30 2006-05-15 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
ES2250853T3 (es) * 2003-08-29 2006-04-16 Les Laboratoires Servier Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables.
DE60308102T2 (de) * 2003-08-29 2007-06-21 Les Laboratoires Servier Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
PT1420028E (pt) * 2003-11-19 2007-05-31 Servier Lab Processo de síntese do perindopril e dos seus sais farmacêuticamente aceitáveis.

Also Published As

Publication number Publication date
DE60302287D1 (de) 2005-12-22
JP4331206B2 (ja) 2009-09-16
JP2007526902A (ja) 2007-09-20
EA200600454A1 (ru) 2006-08-25
US20070010572A1 (en) 2007-01-11
MY136638A (en) 2008-11-28
AU2004270428B2 (en) 2008-08-21
PL211508B1 (pl) 2012-05-31
US7534896B2 (en) 2009-05-19
SI1380591T1 (sl) 2006-02-28
ZA200601429B (en) 2007-05-30
DE60302287T2 (de) 2006-08-10
ES2252633T3 (es) 2006-05-16
AU2004270428A1 (en) 2005-03-17
HK1096408A1 (en) 2007-06-01
NZ545336A (en) 2009-03-31
EP1380591B1 (fr) 2005-11-16
EA008668B1 (ru) 2007-06-29
CN100383160C (zh) 2008-04-23
PL379628A1 (pl) 2006-10-30
EP1380591A1 (fr) 2004-01-14
AR045516A1 (es) 2005-11-02
ATE310012T1 (de) 2005-12-15
WO2005023842A1 (fr) 2005-03-17
CN1835966A (zh) 2006-09-20

Similar Documents

Publication Publication Date Title
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
HK1089188A1 (en) Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
HK1095839A1 (en) Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
DK1614687T3 (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf
DK1321471T3 (da) Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
DK1403275T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367063T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DK1422236T3 (da) Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf